Bioventus Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Bioventus Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue573.28512.35512.12430.90321.16
Cost of Revenue185.05184.15181.04128.1987.64
Gross Profit388.23328.19331.08302.71233.52
Operating Expenses
Research & Development13.6413.4523.8519.0411.20
Selling, General & Administrative327.09303.88332.13254.25193.08
Operating Expenses348.38326.17365.74275.98211.72
Operating Income39.84-81.73-34.6612.0621.80
Other Income/Expense
Interest Income0.000.006.402.731.60
Interest Expense-38.79-40.6812.02-3.849.75
Other Income/Expense0.3481.62-142.354.163.87
Income
Income Before Tax-49.13-121.11-189.037.6215.91
Income Tax Expense-5.290.09-44.37-1.971.19
Net Income-33.54-156.23-158.7019.3816.41
Net Income - Continuous Operations-33.54-121.20-144.6511.450.00
Net Income - Discontinued Operations0.00-74.43-68.74-1.870.00
EBITDA58.98-62.92-121.6142.5054.31
EBIT39.84-120.29-177.007.6225.67
Depreciation & Amortization19.148.849.758.367.44
Earnings Per Share
Basic EPS-1.00-2.00-3.00--
Diluted EPS-1.00-2.00-3.00--
Basic Shares Outstanding64.5562.6561.3945.4737.70
Diluted Shares Outstanding64.5562.6561.3945.4737.70